Table 1 CC50 values for novel HDAC inhibitors in urothelial carcinoma cell lines
From: Effects of novel HDAC inhibitors on urothelial carcinoma cells
19e | 19h | 19i | |
|---|---|---|---|
VM-CUB1 | 2.35 | 2.24 | 0.97 |
UM-UC-3 | 2.54 | 2.20 | 0.82 |
639-V | 2.86 | 3.27 | 1.03 |
HBLAK | n.d. | n.d. | > 5 |
HEK-293 | n.d. | n.d. | 0.61 |
VM-CUB1-LV | n.d. | n.d. | 0.95 |
VM-CUB-HDAC4 | n.d. | n.d. | 0.63 |
UM-UC-3-LV | n.d. | n.d. | 0.79 |
UM-UC-3-HDAC4 | n.d. | n.d. | 0.74 |